Public-registry trials using loratadine 10 mg that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis | Andover Research Eye Institute | Allergic Conjunctivitis | PHASE4 | 1 |
| First registered study | September 2007 — NCT00525382 (UCB Pharma) |
| Registered studies matching this name | 56 all-time · 1 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Allergic Conjunctivitis drugs
← Eichor home · All tracked trials · Allergic Conjunctivitis studies · Weekly briefs